Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

22.08.2022

2 Br J Surg
1 Curr Treat Options Oncol
1 Eur J Cancer
1 Gut
1 J Clin Oncol
1 PLoS One



    Br J Surg

  1. SILVA ANS, Saito Y, Yoshikawa T, Oshima T, et al
    Author response to: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:e106.
    >> Share

  2. LIU K, Hu JK
    Comment on: Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
    Br J Surg. 2022;109:e105.
    >> Share


    Curr Treat Options Oncol

  3. FONG C, Johnston E, Starling N
    Neoadjuvant and Adjuvant Therapy Approaches to Gastric Cancer.
    Curr Treat Options Oncol. 2022 Aug 18. pii: 10.1007/s11864-022-01004.
    >> Share


    Eur J Cancer

  4. POLEE IN, Hermans BCM, van der Zwan JM, Bouwense SAW, et al
    Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study.
    Eur J Cancer. 2022;172:252-263.
    >> Share


    Gut

  5. LENTI MV, Broglio G, Di Sabatino A
    Unravelling the risk of developing gastric cancer in autoimmune gastritis.
    Gut. 2022 Aug 18. pii: gutjnl-2022-328345. doi: 10.1136/gutjnl-2022-328345.
    >> Share


    J Clin Oncol

  6. PATEL MA, Kratz JD, Lubner SJ, Loconte NK, et al
    Esophagogastric Cancers: Integrating Immunotherapy Therapy Into Current Practice.
    J Clin Oncol. 2022 Jul 15:JCO2102500. doi: 10.1200/JCO.21.02500.
    >> Share


    PLoS One

  7. GURNEY J, Whitehead J, Kerrison C, Stanley J, et al
    Equity of travel required to access first definitive surgery for liver or stomach cancer in New Zealand.
    PLoS One. 2022;17:e0269593.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016